SCHEMBL26962452

SCHEMBL26962452

O=C(O)c1ccc2sc(-c3cccnc3)nc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.61
RAB9A P51151 5/20 0.61
KDM4E B2RXH2 3/20 0.58
NFKB1 P19838 3/20 0.58
NFKB2 Q00653 3/20 0.58
RELA Q04206 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
LMNA P02545 1/20 0.58
KMO O15229 1/20 0.55
MKNK1 Q9BUB5 1/20 0.54
MKNK2 Q9HBH9 1/20 0.54
HDAC6 Q9UBN7 2/20 0.53
DYRK1A Q13627 7/20 0.52
FHIT P49789 1/20 0.49
HPGD P15428 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
STAT1 P42224 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17801688 0.89 KDM4E (0.74) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL1744060 0.86 SMN1; SMN2 (0.77) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL29858314 0.83 CDC7 (0.54) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL26962761 0.83 CDC7 (0.54) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL21708400 0.81 NPC1 (0.66) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL17801309 0.79 NPC1 (0.55) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL24366502 0.79 NPC1 (0.66) NPC1RAB9AKDM4ESMN1; SMN2MKNK1
SCHEMBL11778341 0.79 NPC1 (0.66) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL31219277 0.79 NPC1 (0.66) NPC1RAB9AKDM4ENFKB1NFKB2
SCHEMBL22663902 0.78 RAB9A (0.64) NPC1RAB9AKDM4ENFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150339-A1 Compounds and Their Use as PDE4 Activators MIRONID LIMITED (GB) 2024-05-09 US disclosed
EP-4291557-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS Mironid Limited (GB) 2023-12-20 EP disclosed
CN-116848107-A Compounds and their use as PDE4 activators 米罗尼德有限公司 2023-10-03 CN disclosed
WO-2022172037-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS MIRONID LIMITED (GB) 2022-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150339-A1 Compounds and Their Use as PDE4 Activators PDE4A, PDE4B, PDE4C NPC1 3795/4885RAB9A 1715/4885KDM4E 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.